AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 APR 10 - (NewsRx.com & NewsRx.net) -- Non-Hodgkin's Lymphoma, a new report from Decision Resources, Inc., forecasts that sales of pharmaceuticals to treat non-Hodgkin lymphoma (NHL), will more than triple between 2000 and 2010 in the major pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan).
Factors that will contribute to this growth include the following:
* A 4.5% per year increase in the NHL population in the major pharmaceutical markets.
* Increased rituximab use due to extended labeling.
* The ...
Source: HighBeam Research, Non-Hodgkin lymphoma treatment market will experience rapid growth...